Only in Titles

           Search results for: GFP Expressing Human Coronary Artery Endothelial Cells   

paperclip

#24705272   // Save this To Up

Reversal of ischemic cardiomyopathy with Sca-1+ stem cells modified with multiple growth factors.

We hypothesized that bone marrow derived Sca-1+ stem cells (BM Sca-1+) transduced with multiple therapeutic cytokines with diverse effects will induce faster angiomyogenic differentiation in the infarcted myocardium.

1421 related Products with: Reversal of ischemic cardiomyopathy with Sca-1+ stem cells modified with multiple growth factors.

Growth Factor (Human) Qua Macrophage Colony Stimula Human Angiopoietin Growth StemBoost(TM) Growth Fact Angiogenesis (Human) Quan 129 Mouse Embryonic Stem Epidermal Growth Factor ( StemBoost(TM) Growth Fact Rat Mesenchymal Stem Cell Stemez hN2 Human Neuron D StemBoost(TM) Growth Fact Epidermal Growth Factor (

Related Pathways

paperclip

#20730500   // Save this To Up

Tracking long-term survival of intramyocardially delivered human adipose tissue-derived stem cells using bioluminescence imaging.

Transplantation of a regenerative cell population derived from human subcutaneous adipose tissue (hASCs) for cardiac regeneration represents a promising therapy due to the capacity of these cells for proliferation and differentiation. Understanding the fate of injected hASCs would help to understand how hASCs work in vivo. The aim of this study was to track the long-term fate, including survival, differentiation, proliferation, apoptosis, migration, and growth factor secretion of intramyocardially injected hASCs following experimental acute myocardial infarction in an immunodeficient mouse model.

2246 related Products with: Tracking long-term survival of intramyocardially delivered human adipose tissue-derived stem cells using bioluminescence imaging.

Human Cord Blood CD34+ Ce Stemez hN2 Human Neuron D Macrophage Colony Stimula Goat Anti-Human Tissue Fa LumiSTEM 96 iPS MSC deriv Macrophage Colony Stimula 1,1'-Dioctadecyl-3,3,3',3 Amyloid Precursor Protein Goat Anti-Human DAP10 HCS Goat Anti-Human FAPP2 PLE GFP Expressing Human Live Rabbit Anti-Human SMIT-1

Related Pathways

paperclip

#19479297   // Save this To Up

Genetic engineering with endothelial nitric oxide synthase improves functional properties of endothelial progenitor cells from patients with coronary artery disease: an in vitro study.

Recent studies have reported a marked impairment in the number and functions of endothelial progenitor cells (EPCs) in patients with coronary artery disease (CAD). In view of an important role of eNOS in angiogenesis, in the present study, we evaluated the effects of eNOS gene transfer in ex vivo expanded EPCs isolated from patients with CAD. The expanded EPCs were transfected with mammalian expression vector pcDNA3.1-eNOS containing the full-length human eNOS gene using lipofectamine. About 35-40% of the eNOS-EPCs had higher expression of eNOS as compared to untransfected EPCs. EPCs transfected with pcDNA3.0-EGFP, the plasmid vector expressing green fluorescent protein (GFP) were used as control. The untransfected, GFP-transfected and eNOS-transfected EPCs were compared in terms of important functional attributes of angiogenesis such as proliferation, migration, differentiation and adhesion/integration into tube-like structures in vitro. Functional studies revealed that in the presence of defined growth conditions, compared to the untransfected and GFP-transfected cells, eNOS-EPCs from patients with CAD have a significant increase in [3H] thymidine-labeled DNA (P < 0.01), migration (14.6 +/- 1.8 and 16.5 +/- 1.9 vs. 23.5 +/- 3.4 cells/field, P < 0.01), ability to differentiate into endothelial-like spindle-shaped cells (46 +/- 4.5 and 56.5 +/- 2.1 vs. 93.2 +/- 6.6 cells/field, P < 0.001) and also incorporation into tube-like structures on the matrigel (GFP-EPCs: 21.25 +/- 2.9 vs. GFP-eNOS-EPCs: 34.5 +/- 5.5 cells/field, P < 0.05). We conclude that eNOS gene transfection is a valuable approach to augment angiogenic properties of ex vivo expanded EPCs and eNOS-modified EPCs may offer significant advantages than EPCs alone in terms of their clinical use in patients with myocardial ischemia.

2385 related Products with: Genetic engineering with endothelial nitric oxide synthase improves functional properties of endothelial progenitor cells from patients with coronary artery disease: an in vitro study.

Rabbit Anti-Nitric Oxide Rabbit Anti-Nitric Oxide GFP Expressing Human Coro Rabbit Anti-Nitric Oxide Human Coronary Artery End Cultrex In Vitro Angiogen GFP Expressing Human Inte Human Internal Mammary Ar Rat Anti-Human Endothelia Human Iliac Artery Endoth Human Aortic Artery Endot Human Large Intestine Mic

Related Pathways

paperclip

#16603183   // Save this To Up

Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair.

We postulated that combining cell based hVEGF165 gene delivery with cytokine-induced mobilization of bone marrow cells (BMC) may give better prognosis in an infarcted heart. Forty-eight myoabalated female C57BL/6J mice (20-25 g) received 1 x 10(6) BMC from transgenic GFP+ male mice. One month later, acute myocardial infarction (MI) model was developed by coronary artery ligation. Animals were grouped (N = 12) to receive intramyocardial injections of 10 microl DMEM without cells (group 1; group 2) or with 1x10(5) mesenchymal stem cells (MSC) over-expressing hVEGF165 (group 3; group 4). The animals received either cytokine therapy (group 2 and 4) or saline solution (group 1 and 3) for 7 days after MI. Hemodynamic data were obtained 4 weeks after MI using Millar's P-V system and cardiac tissue was harvested for immunohistological studies. We observed regeneration and extensive survival of BMC in and around the infarcted myocardium in groups 3 and 4. Blood vessel density was markedly enhanced in group 4 as compared with groups 1 and 2 in peri-infarct area. Fibrotic area was significantly reduced with improved LV-contractile function in group 2 and 4. LV-systolic and diastolic functions were well-preserved in group 4 as indicated by +dP/dt, -dP/dt and Tau (glantz). We therefore conclude that transplantation of MSC overexpressing VEGF combined with cytokine induced BMC mobilization is superior to either of the monotherapy approach for angiomyogenesis and LV-function recovery.

1122 related Products with: Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair.

Rabbit Anti-VEGF Polyclon Rabbit Anti-phospho-cardi Rabbit Anti-VEGF Polyclon Rabbit Anti-phospho-cardi Rabbit Anti-VEGFR2 Polycl RFP Expressing Human Umbi Rabbit Anti-VEGFR2 Polycl 4-Amino-5-formylamino-3-i Rabbit Anti-Nkx2.5 Cardia Recombinant Human VEGF VE Rabbit Anti-Nkx2.5 Cardia Rabbit Anti-VEGFR3(mouse,

Related Pathways

  •  
  • No related Items